196 related articles for article (PubMed ID: 36291742)
21. A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.
Kato A; Ng S; Thangasamy A; Han H; Zhou W; Raeppel S; Fallon M; Guha S; Ammanamanchi S
Mol Carcinog; 2021 Nov; 60(11):734-745. PubMed ID: 34347914
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma.
Li N; Li Y; Li Z; Huang C; Yang Y; Lang M; Cao J; Jiang W; Xu Y; Dong J; Ren H
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271610
[TBL] [Abstract][Full Text] [Related]
23. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
[TBL] [Abstract][Full Text] [Related]
24. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
Fu Y; Liu S; Zeng S; Shen H
Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
[TBL] [Abstract][Full Text] [Related]
25. Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.
Xiang J; Liu L; Wang W; Xu H; Wu C; Xu J; Liu C; Long J; Ni Q; Yu X
Cancer Lett; 2015 Apr; 359(2):165-8. PubMed ID: 25617800
[TBL] [Abstract][Full Text] [Related]
26. Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma.
Bauden M; Kristl T; Sasor A; Andersson B; Marko-Varga G; Andersson R; Ansari D
BMC Cancer; 2017 Dec; 17(1):810. PubMed ID: 29197353
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
Mittal K; Kaur J; Sharma S; Sharma N; Wei G; Choudhary I; Imhansi-Jacob P; Maganti N; Pawar S; Rida P; Toss MS; Aleskandarany M; Janssen EA; Søiland H; Gupta MV; Reid MD; Rakha EA; Aneja R
Mol Cancer Res; 2022 Apr; 20(4):596-606. PubMed ID: 34933912
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma.
Tanaka T; Li TS; Urata Y; Goto S; Ono Y; Kawakatsu M; Matsushima H; Hirabaru M; Adachi T; Kitasato A; Takatsuki M; Kuroki T; Eguchi S
J Gastroenterol; 2015 Sep; 50(9):975-83. PubMed ID: 25542265
[TBL] [Abstract][Full Text] [Related]
29. CypA, a gene downstream of HIF-1α, promotes the development of PDAC.
Zhang H; Chen J; Liu F; Gao C; Wang X; Zhao T; Liu J; Gao S; Zhao X; Ren H; Hao J
PLoS One; 2014; 9(3):e92824. PubMed ID: 24662981
[TBL] [Abstract][Full Text] [Related]
30. Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression.
Chen K; Wang Q; Liu X; Wang F; Yang Y; Tian X
Int J Biol Sci; 2022; 18(3):1220-1237. PubMed ID: 35173549
[No Abstract] [Full Text] [Related]
31. IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer.
Yang J; Liu DJ; Zheng JH; He RZ; Xu DP; Yang MW; Yao HF; Fu XL; Yang JY; Huo YM; Tao LY; Hua R; Sun YW; Kong XM; Jiang SH; Liu W
Cell Oncol (Dordr); 2022 Jun; 45(3):367-379. PubMed ID: 35486320
[TBL] [Abstract][Full Text] [Related]
32. The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer.
Song Z; Ren H; Gao S; Zhao X; Zhang H; Hao J
Tumour Biol; 2014 Nov; 35(11):11319-28. PubMed ID: 25119596
[TBL] [Abstract][Full Text] [Related]
33. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
[TBL] [Abstract][Full Text] [Related]
35. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
36. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.
Zhang G; He P; Tan H; Budhu A; Gaedcke J; Ghadimi BM; Ried T; Yfantis HG; Lee DH; Maitra A; Hanna N; Alexander HR; Hussain SP
Clin Cancer Res; 2013 Sep; 19(18):4983-93. PubMed ID: 23918603
[TBL] [Abstract][Full Text] [Related]
37. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
38. Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes.
de Koning W; Latifi D; Li Y; van Eijck CHJ; Stubbs AP; Mustafa DAM
Front Immunol; 2021; 12():649061. PubMed ID: 33986743
[TBL] [Abstract][Full Text] [Related]
39. Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification.
Chen Y; Chen D; Wang Q; Xu Y; Huang X; Haglund F; Su H
Front Immunol; 2021; 12():719105. PubMed ID: 35111149
[TBL] [Abstract][Full Text] [Related]
40. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
